An endogenous peptide associated with sleep modulation and stress responses; older human studies are mixed and it is not an approved therapy.
DSIP (delta sleep-inducing peptide) is a naturally occurring peptide first identified in the 1970s for its apparent link to deep sleep.
Despite decades of study, its exact receptor and mechanism remain poorly defined. It's proposed to modulate sleep patterns, the body's stress (HPA) axis, and the opioid and GABA systems — but these remain loosely characterized.
Reflecting that uncertainty, the older human data are mixed, and it is not an approved therapy. It's a good example of a peptide where the honest 'how it works' answer is largely 'we don't fully know.'
Searching the published record…
Searching the published record…
Searching the published record…
No indexed animal studies found for this term. Try the live PubMed query below.
Search this category on PubMed →Studies are surfaced live from the U.S. National Library of Medicine (PubMed). biohackr indexes and links the published record; it does not host or alter source articles.